Latest News about cancer
Recent news which mentions cancer
From Benzinga
Gilead's Kite Pharma Collaborates With Shoreline Biosciences For Cell Therapies For Cancer Settings
June 17, 2021
Tickers
GILD
From Benzinga
Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights
June 14, 2021
Tickers
AVCO
From Benzinga
Tickers
ENB
VBI Vaccines' Brain Cancer Immunotherapy Gets FDA Fast Track Review; Announces Updated Tumor Response, Overall Survival Data
June 08, 2021
From Benzinga
PDS Biotech's Lead Versamune Program Achieves Overall Tumor Reduction of 67% In HPV16 Positive Cancer Patients
June 08, 2021
Tickers
PDSB
From Benzinga
Hookipa Pharma's Cancer Immunotherapy Shows T-Cell Response, Interim Efficacy in Pretreated HPV16+ Cancer Settings
June 08, 2021
Tickers
HOOK
From Benzinga
From Benzinga
Coherus, Junshi Toripalimab-Chemo Combo Beat Chemo Alone in Late-Stage Nose & Throat Cancer Trial
June 04, 2021
Tickers
CHRS
From Benzinga
From PRUnderground
Monopar, National University of Singapore Team Up For Preclinical Assessment Of MNPR-202 In Cancer Settings
June 03, 2021
Tickers
MNPR
From Benzinga
From Benzinga
Corbus In-Licenses Two Anti-Integrin Antibodies Targeting Cancer, Fibrotic Diseases Settings
June 01, 2021
Tickers
CRBP
From Benzinga
CTI BioPharma Shares Shoot Higher as FDA Accepts Pacritinib Review Application In Bone Marrow Cancer
June 01, 2021
Tickers
CTIC
From Benzinga
Regeneron-Sanofi's Libtayo Scores CHMP's Positive Opinion For Two Advanced Cancer Settings
May 24, 2021
From Benzinga
From Benzinga
Adaptimmune's Stock Trades Higher As TCR Therapy Shows Initial Durability In Soft Tissue Cancer Settings
May 20, 2021
Tickers
ADAP
From Benzinga
I-Mab Showcases Early Data On Uliledlimab/Atezolizumab Combo In Advanced Cancer Settings
May 20, 2021
From Benzinga
Affimed's AFM13 In Combination With NK Cells Show Improved Tumor Recognition, Killing In Preclinical Studies
May 14, 2021
Tickers
AFMD
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.